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Abstract 
Background 
Hypertension is a risk for brain ageing, but the mechanisms underlying this effect remain 
unclear. MRI detected biomarkers of brain ageing include white matter hyperintensities 
(WMH); a marker of cerebrovascular disease, and hippocampal volume, a marker of 
Alzheimer’s disease pathology. 
Objective 
To examine relationships between blood pressure (BP) components and brain pathology in 
older adults.  
Subjects 
227 members of the Aberdeen 1936 Birth Cohort between ages 64y and 68y.  
Methods 
BP was assessed biennially between 64 to 68y and brain MRI performed at 68y. The risk 
factors of interest were diastolic and systolic BP and their visit-to-visit variability. Outcomes 
were white matter hyperintensity abundance, and hippocampal volume. Regression models, 
controlling for confounding factors, examined their relationships.  
Results 
Higher diastolic BP predicted increased WMH (β=.13, p = .044) and smaller hippocampi (β=-
.25, p=.006). In contrast, increased systolic BP predicted larger hippocampi (β=.22, p=.013). 
Variability of diastolic BP predicted lower hippocampal volume (β=-.15, p=.033). These 
relationships were independent of confounding life-course risk factors. Anti-hypertensive 
medication did not modify these relationships, but was independently associated with 
increased WMH (β=.17, p=.011).  
Conclusions 
Increased diastolic BP is associated with biomarkers of both cerebrovascular and 
Alzheimer’s diseases, whereas the role of systolic BP is less clear, with evidence for a 
protective effect on hippocampal volume. These differing relationships emphasises the 
importance of considering individual BP components with regards to brain ageing and 
pathology. Interventions targeting diastolic hypertension and its chronic variability may 
provide new strategies able to slow the accumulation of these harmful pathologies.   
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Introduction 
Hypertension is common in older age [1] and is linked to MRI markers of brain 
degeneration that accompany ageing and dementia. Cerebrovascular disease is visible on 
MRI scans as hyper-intense regions named white matter hyperintensities (WMH). Although 
first detected within the white matter, WMH have been shown to be present throughout 
the brain [2]. WMH are associated with reduced cognitive performance and dementia [3, 4], 
and are more prevalent in older adults with hypertension than normotensive controls [5]. 
We have shown that the negative influence of hypertension on cognition was entirely 
explained by the WMH burden in normal ageing [5]. Some evidence suggests the 
relationship between blood pressure (BP) and cognition in the elderly is non-linear with 
hypotension associated with faster decline in older adults with cognitive impairment; [6] 
nevertheless, the association between hypotension and brain pathology remains unknown. 
A relationship between hypertension and dementias, including Alzheimer’s disease 
and vascular dementia, is widely accepted [7], although evidence in support of treatment of 
hypertension to prevent dementia is somewhat conflicting [8, 9]. The relationships between 
BP, cognition and brain ageing are not straight-forward with a systematic review finding 
reports of positive, negative, U shaped, J shaped and quadratic relationships between BP 
and cognitive function. Furthermore, it has been demonstrated that diastolic (dBP) and 
systolic blood pressure (sBP) can have independent relationships with cognition [7].  
Reduced hippocampal volume is a marker of hippocampal atrophy and is a useful 
indication of Alzheimer’s pathology [10]. The LADIS study found no association between BP 
and medial temporal lobe volume (including the hippocampus) in an ageing cohort [11], 
whereas, the Honolulu ageing project found that both diastolic and systolic midlife 
hypertension were associated with reduced hippocampal size in late life [12]. 
BP variability has been implicated as an independent vascular risk factor [13]. 
Patients with vascular dementia have greater sBP variability (over 24h) than controls [14]. In 
patients with Alzheimer’s disease, greater visit-to-visit sBP variability predicted cognitive 
decline [15]. 
Although it is plausible that the relationship between hypertension and brain 
pathologies is causal, alternative hypotheses exist. Early life socioeconomic circumstance is 
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related to late-life hippocampal volume and WMH abundance [16, 17]. Furthermore, it has 
been found that prenatal stress can increase the risk of adult hypertension [18]. Therefore, 
hypertension and brain deterioration could share a common cause. A further potential 
factor that could influence these relationships is the use of anti-hypertensive treatments, 
that could mask hypertension related brain deterioration, or successfully ameliorate their 
effects. 
Here we test the hypothesis that BP components and variability have 
heterogenous relationships with WMH and hippocampal volume. We analysed the data 
from Aberdeen Birth Cohort of 1936 for whom extensive life course data are available.  
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Methods 
Participants and sampling 
In 2000 we recruited 497 participants of the 1947 Scottish Mental Survey, aged 64 years, 
into the Aberdeen Birth Cohort of 1936. In 2004, 244 participants entered a brain MRI sub-
study. MRI data suitable for inclusion were obtained from 227 (WMH) and 225 
(hippocampal volume). The Grampian Research Ethics Committee approved the study and 
informed written consent was obtained from all participants. 
Brain MRI acquisition and analysis 
Brain MRI examinations were carried out (1.5T NVi GE system, Milwaukee, Wi) using 
T2 axial (TR/TE 4900/81.4, slice thickness 5mm, space 1.2mm), fluid attenuation inversion 
recovery axial (FLAIR) (TR/TE 9002/1.33, TI 2200, slice thickness 5 mm, space 1.2 mm) and 
3D T1 weighted (TR/TE 20/6ms, flip angle 35o, slice thickness 1.6mm, matrix 256x192, in-
plane resolution 1x1mm) sequences [5]. T2 and FLAIR images were analysed by a 
neuroradiologist, using Scheltens’s scale which assesses brain WMH [19]. Whole brain WMH 
score was calculated and due to a non-normal distribution was was log transformed for 
subsequent analyses. The T1W images were processed on a PC running Scientific LINUX 
(version 5.5). The volumetric segmentation of hippocampus and total intracranial volume 
(TICV) were performed using FreeSurfer (version 4.5.0) 
(http://surfer.nmr.mgh.harvard.edu). The sum of hippocampal volumes, corrected for TICV, 
was used for all subsequent analyses. 
BP components  
BP was assessed biennially on three occasions (waves 1, 2 and 3: w1, w2, w3) 
between 2000 and 2004. Measurements were taken, after five minutes seated in a warm 
quiet room, by a trained nurse using an Omicron BP monitor using an appropriately sized 
cuff. At each measurement wave sBP and dBP were measured three times and their means 
recorded. The overall mean of the three waves for sBP and dBP were then calculated. From 
these mean values, the inter-session coefficients of variability (CV; ratio of standard 
deviation to mean, expressed as percentage) of sBP and dBP were calculated (sBPvar, 
dBPvar respectively).  
Antihypertensive treatment  
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At each wave, participants were asked to list all medications. These records were 
examined for anti-hypertensive (AH) medications. Data were collated and coded as “0”, no 
AH treatment; and “1”, AH treatment at one or more waves.  
Childhood occupational social circumstance  
For childhood occupational social circumstance (cOSC), paternal occupational grade 
at participant age 11 was coded according to the UK's Office of Population Statistics 
classification: 1, managerial; 2, professional; 3, lesser professional; 4, secretarial; 5, skilled 
manual; 6, semi-skilled; 7,  lesser semi-skilled; 8, unskilled , and 9, lesser unskilled. This gives 
higher status occupations a lower score [20]. Those with cOSC grades 1-4, and 5-9 were 
recoded as high (‘2’) and low (‘1’) cOSC respectively. For clarity in interpretation of 
regression analyses, higher status occupations were assigned the larger code. Dichotomous 
recoding was performed based on evidence that the influence of cOSC on brain pathology is 
non-linear, with a step change increase in risk between skilled the manual and secretarial 
grades [16, 17]. 
Statistical Analysis 
To examine BP component changes over the 3 waves of measurement, repeated 
measures ANOVA with Tukey’s range post hoc test and a test for linear trend were 
performed. 
Multiple regression was performed with log transformed WMH score and total 
hippocampal volume, corrected for cranial volume, as dependent variables. Missing values 
(<5%) were replaced with the sample mean. Linearity was investigated by comparing a 
linear to a quadratic response in hierarchical regression models for all BP variables, and 
examining change statistics between linear and quadratic models. There was no significant 
evidence of non-linear relationships in any model. Exploratory analyses found age at MRI 
correlated with WMH and hippocampal volume and found gender differences in 
hippocampal volumes, therefore, these confounding variables were added to all relevant 
models. 
Sources of Funding 
This work was supported by Alzheimer's Research Trust (now Alzheimer's Research UK) and 
the University of Aberdeen Development Trust.  
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Results 
Study population 
This sample comprised 227 participants (male 48%, mean age at w1 = 64.5y, SD = 
0.81y). dBP and sBP at age 64y did not differ between the study sample and the members of 
ABC1936 not included.  
BP characteristics & anti hypertensives (AH) 
101 (45%) of participants reported taking AH medication on at least one study wave. 
Three wave means (SD) of sBP and dBP were 139.9 (1.52) mmHg and 79.5 (0.93) mmHg 
respectively. Although no significant differences were found between waves, a significant 
negative slope for mean dBP was detected. BP variables were significantly elevated in the 
AH group (Table 1).  
Relationships between BP components and WMH 
Table 2 shows the relationships between BP and WMH including confounding 
variables and AH treatment. Age was positively associated with WMH in models 1,3 and 4. 
In relevant models, increased dBP, but not sBP, predicted greater WMH (Models 1 and 2). 
sBP and dBP variability were not associated with WMH (Model 2). Model 3 adds cOSC, and 
finds a trend for higher cOSC to predict reduced WMH. Adding AH treatment in Model 4 
finds that AH treatment was significantly, independently, associated with greater WMH, and 
that higher status cOSC was associated with lower WMH. 
Relationship between BP components and hippocampal volume 
Table 3 details regression models that examined the relationships between BP 
components and hippocampal volume. All models demonstrate that higher dBP but lower 
sBP were associated with reduced hippocampal volume (Models 5-8). Model 6 shows that 
increased dBPvar was independently associated with reduced hippocampal volume, 
whereas sBPvar was not. 
Model 7 adds the putative hippocampal volume modifying factor cOSC, and did not 
find a relationship with hippocampal volume. AH treatment was not associated with 
hippocampal volume (Model 8) in adjusted models.   
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Discussion 
Overview of findings 
In this study, we explore the chronic effects of BP components on brain imaging 
biomarkers of cerebral small vessel disease and Alzheimer’s pathology in a normal ageing 
cohort. We find that increased diastolic BP is significantly associated with increased WMH 
burden and reduced hippocampal volume. We also find that increased visit-to-visit 
variability in diastolic BP is independently associated with reduced hippocampal volume.  
BP components and brain hyperintensities 
We demonstrate that elevated dBP is an independent predictor of greater brain 
WMH, a marker of small vessel disease. Relatively few studies have examined diastolic 
versus systolic BP effects on WMH. Aribisala and colleagues found that both systolic and 
diastolic pressure predicted WMH density [21], whereas prospective studies have found 
systolic BP to more strongly predict WMH progression [22]. Recent clinical trials in an older 
cohort (80y) have successfully reduced sBP but without a resultant reduction in WMH 
accumulation [23], suggesting that WMH progression is insensitive to sBP changes in later 
life.  
Although BP variability has been hypothesised as an independent influence on 
cardiovascular diseases including stroke, CVD and early death [13], little is known about its 
relationship with WMH. A prospective study found that increased midlife sBP variability is a 
risk factor for WMH in late-life [24], others have found WMH progression to be unaffected 
by BP variability [25]. We found no association between BP variability and WMH, adding to 
the evidence that BP variability does not promote WMH.  
BP components and hippocampal volume 
The relationship between BP and dementia, in particular Alzheimer’s disease, is not 
straightforward [7]. Several large-scale prospective studies found that mid-life hypertension 
increased the risk of future dementia [26] and medial temporal lobe atrophy in later life 
[12]. Other studies, however, found low systolic BP to be associated with dementia [27]. 
We find that increased dBP predicts reduced total hippocampal volume, whereas 
sBP is associated with greater hippocampal volume when other BP components are 
included. It is interesting to note that the apparent protective effect of sBP on the 
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hippocampus is only detectable when the negative association between dBP and 
hippocampal volume is accounted for in the model. This supports the evidence that 
relationship between BP and brain health is more complex than previously thought. One 
possible mechanism underlying this finding is that increased dBP is a risk factor or marker of 
early Alzheimer’s pathology in this ageing sample, whereas increased sBP protects 
hippocampal volume from the deleterious effects of dBP through the maintenance of blood 
supply [28]. Classifications of older people into binary groups of hypertensives versus non-
hypertensives may obscure important markers of brain ageing risk informed by considering 
independent BP components.  
Visit-to-visit BP variability has been proposed as a risk for Alzheimer’s disease 
progression, with visit-to-visit sBP variability associated with cognitive decline in Alzheimer’s 
patients.[15] Furthermore, dBP and sBP variability has been associated with increased risk 
of incident dementia [29], We found that in our dementia free cohort, diastolic variability is 
associated with lower hippocampal volume independently of mean BP. This finding suggests 
that dBP variability may increase risk of Alzheimer’s disease, or accelerate the development 
of pre-existing pathologies.  
Whilst we cannot confirm higher dBP and its variability are risk factors for rather 
than consequences of brain pathology, it is plausible and also more likely that brain damage 
is caused by BP fluctuations disrupting the microvascular structure of the hippocampus, and 
other brain tissues [12]. 
Antihypertensive (AH) medication 
We found greater WMH in the AH group was independent of the influence of dBP. It 
is highly likely AH treatment is an indication of chronic, more severe pre-treatment 
hypertension, and increased pathology was a consequence of this earlier exposure to 
hypertension. It is possible, however, that AH treatment may be a direct risk for WMH. 
Indeed, Hogh et al reported WMH progression associated with AH treatment, but not 
hypertension itself, in older age [30].  
Childhood Occupational Social Circumstances 
It is plausible that poor early life socioeconomic circumstances may increase the risk of late 
life pathology through hypertension. As previously shown, [17] we find an independent 
association between lower cOSC and increased WMH, possibly an indication of early life 
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programming of WMH risk in later life. We found no association between cOSC and 
hippocampal volume, in contrast to our previously finding [16]. This previous investigation 
of cOSC and late life hippocampal volume did not include hypertension as a mediating 
mechanism. This suggests that cOSC may influence hippocampal atrophy indirectly, through 
early life programming of late-life blood pressure dysfunction.  
Strengths of this Study 
We measured BP at three time points over 4 years giving a reliable and robust 
measurement of chronic BP exposure. The study population is a normal ageing cohort, free 
from dementia at recruitment, and a relevant study population for investigating 
hypertension. Uniquely, members of ABC1936 share many of the same life-course factors 
which can impact on later life and we additionally adjusted for age within this narrow age 
range sample. Furthermore, we accounted for other variables hypothesised to influence 
brain ageing. The use of MRI for the quantification of brain pathology allows sensitive and 
validated measures of hippocampal volume and WMH [2].  
Limitations 
Although causal relationships cannot be assumed, it is unlikely brain pathologies 
would determine BP in a dementia-free sample. This study did not correct for all potential 
cardiovascular risk factors for brain pathology, and therefore it is not known if these 
elements interact or modify the BP and brain pathology findings presented here. The use of 
the Scheltens’s WMH visual rating scale can be criticised for vulnerability to inter-rater 
variability and ceiling effects, however it has been well validated and compares well with 
automated methods. The healthy volunteer effect causes ABC1936 to be relatively 
advantaged compared to the general population. This selection bias would be likely to 
underestimate the strength of these findings in the general population.  
Conclusions 
Our findings provide insight into the complex and differing relationships between BP 
components and brain pathology, and may explain the heterogeneous relationships 
between BP and cognition reported in previous studies. Treating systolic hypertension may 
have the consequence of accelerating hippocampal atrophy, whereas treating diastolic 
hypertension, and reducing its long–term variability could ameliorate hippocampal atrophy 
and cerebrovascular disease, both risk factors for dementia: Given this potential dual action, 
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targeting diastolic hypertension should be a primary goal for reducing neurodegeneration in 
older age.  
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Table 1. BP, BP components and brain MRI pathology biomarkers in participants with and without anti-hypertensive medication. Sample 
includes 119 men and 108 women of Aberdeen Birth Cohort 1936 aged 64y. 
  
Prescribed Anti-Hypertensive Medication 
  
  No  Yes  t-test 
  Mean SEM N  Mean SEM N  p-value 
sBP (mmHg) 
 
136.8 1.3 124  143.7 1.6 99  0.001 
dBP (mmHg) 
 
78.3 0.7 124  81.1 0.7 99  0.005 
sBPvar (%) 
 
5.7 0.3 124  8.2 0.5 99  <0.001 
dBPvar (%) 
 
6.0 0.3 124  7.1 0.4 99  0.033 
WMH 
 
14.7 0.8 126  18.5 1.0 101  0.004 
Total Hippo (%) 
 
0.55 0.01 124  0.53 0.00 101  0.037 
sBP, systolic blood pressure; dBP, diastolic blood pressure; sBPvar, systolic blood pressure variability; dBPvar, diastolic blood pressure 
variability; WMH, white matter hyperintensities; Total Hippo (%), total hippocampal volume as a proportion of intracranial volume; SEM, 
standard error of the mean. 
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Table 2: Results of regression models examining the effect of blood pressure and related variables on total WMH score (N=227). 
Model 1 (BP)   Model 2 (+variability)    Model 3 (+risk factors)   Model 4 (+AH) 
Variable Statistic   Variable Statistic   Variable Statistic   Variable Statistic 
  
Std 
Beta 
p-value     
Std 
Beta 
p-value     
Std 
Beta 
p-value     
Std 
Beta 
p-value 
Age 0.13 0.048  Age 0.13 0.053  Age 0.13 0.043  Age 0.13 0.049 
dBP 0.21 0.036  dBP 0.19 0.046  dBP 0.17 0.012  dBP 0.13 0.044 
sBP -0.04 0.747  sBP -0.03 0.772  cOSC -0.12 0.070  cOSC -0.13 0.048 
    dBPvar -0.04 0.645      AH 0.17 0.011 
    sBPvar 0.05 0.494         
R2 0.050   0.052   0.063   0.90 
Adjusted 
R2 
0.037   0.030   0.051   0.074 
Missing values (<5% of total n) are replaced with sample mean. sBP, systolic blood pressure; dBP, diastolic blood pressure; sBPvar, systolic 
blood pressure variability; dBPvar, diastolic blood pressure variability; WMH, white matter hyperintensities. AH, use of antihypertensive 
medication; cOSC, childhood occupational social class.  
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Table 3: Results of regression models examining the relationship between BP and hippocampal volume (N=227) 
Model 5 (BP)  Model 6 (+variability)  Model 7 (+risk factors)  Model 8 (+AH ) 
Variable Statistic  Variable Statistic  Variable Statistic  Variable Statistic 
 
Std 
Beta 
p-
value 
  
Std 
Beta 
p-
value 
  
Std 
Beta 
p-
value 
  
Std 
Beta 
p-
value 
Gender 0.40 <0.001  Gender 0.38 <0.001  Gender 0.39 <0.001  Gender 0.38 <0.001 
Age -0.07 0.261  Age -0.09 0.138  Age -0.09 0.133  Age -0.09 0.152 
dBP -0.19 0.029  dBP -0.25 0.006  dBP -0.24 0.007  dBP -0.25 0.007 
sBP 0.17 0.046  sBP 0.22 0.013  sBP 0.22 0.013  sBP 0.24 0.009 
    dBPvar -0.15 0.033  dBPvar -0.17 0.008  dBPvar -0.16 0.014 
    sBPvar -0.04 0.600  cOSC 0.05 0.395  AH -0.09 0.163 
R2 0.199  0.226  0.227  0.232 
Adjusted R2 0.184  0.205  0.206  0.211 
Missing values (<5% of total n) are replaced with sample mean. sBP, systolic blood pressure; dBP, diastolic blood pressure; sBPvar, systolic 
blood pressure variability; dBPvar, diastolic blood pressure variability; AH, use of antihypertensive medication; cOSC, childhood occupational 
social class. 
 
 
